MOH says sofosbuvir will be given to medical tourists at private hospitals after procuring the drug under a voluntary licence; WTO rules only allow compulsory licensing for public non-commercial use.
Destigmatisation is an important part of the public health effort in eliminating hepatitis as fear of discrimination and stigma can prevent people from getting tested and treated.